re: Ann: 2nd Quarter Dose Sales Growth 21.6 p... Another great result shame about europe.
Good growth in Asia which will become our biggest market I think.
Regards,
- Forums
- ASX - By Stock
- SRX
- Ann: 2nd Quarter Dose Sales Growth 21.6 per cent
Ann: 2nd Quarter Dose Sales Growth 21.6 per cent , page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online